About the Summit for Cancer Immunotherapy

Led by BioCanRx – Canada’s Immunotherapy Network, the Summit for Cancer Immunotherapy (Summit4CI) provides networking and learning opportunities at both an annual conference and throughout the year.

The highlight of the Summit4CI is an annual conference that brings together up to 350 leading scientists, clinicians, students and economists with representatives from industry, patient groups, charities and government. The conference explores the latest progress in cancer immunotherapy from scientific, clinical, industry and patient perspectives, through internationally recognized speakers, scientific presentations, poster sessions, panel discussions an Oxford-style debate and networking opportunities.

In addition to the main conference programme, our Highly Qualified Personnel (HQP) and Trainee members take part in a pre-conference Development Day as well as a Meet the Experts session.

The Learning Institute, developed by BioCanRx’s Cancer Stakeholder Alliance LI Working Group and our HQP community, brings together leaders from oncology patient communities and academics from the immunotherapy research community. Participants take part in webinars in the lead up to the conference to gain a better understanding of cancer biology and immunotherapy, attend plenaries and engage in knowledge exchange activities and a Patient-Researcher Roundtable event. These activities support BioCanRx’s ultimate goal of increasing patient scholar-researcher collaboration.

Conference programming is developed by Summit4CI Programming Committees comprised of network members.

As part of the Summit4CI annual programming, BioCanRx also hosts:

• A virtual Public Forum focusing on cancer immunotherapy, new therapies and patient access;
• A Speaker Series of webinars focused on professional development and new and emerging topics in Immunotherapy for Cancer research.